Axsome Therapeutics: Q4 Earnings Insights

Comments
Loading...

 

Axsome Therapeutics AXSM reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Axsome Therapeutics beat estimated earnings by 12.62%, reporting an EPS of $-0.9 versus an estimate of $-1.03.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 5.97% drop in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

AXSM Logo
AXSMAxsome Therapeutics Inc
$104.46-0.01%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
92.72
Growth
-
Quality
-
Value
12.86
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: